Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
315.5 INR | +2.45% | +1.15% | +26.38% |
07:14am | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
05-17 | Jefferies Adjusts Biocon’s Price Target to INR230 From INR250, Keeps at Underperform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.38% | 4.42B | |
+10.46% | 115B | |
+12.22% | 106B | |
-5.92% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.60% | 17.56B | |
-40.50% | 17.32B | |
+6.48% | 14.03B | |
+30.33% | 12.13B |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited
- Biocon Signs Deal with Medix for Commercialization of Chronic Weight Management Drug in Mexico